(Total Views: 679)
Posted On: 04/24/2020 12:30:05 PM
Post# of 154912
ohm20 wrote:
In fact, nothing would make me happier than for Vyera to be in breach of the commercialization agreement due to lack of funds. I know that the negotiated 50% royalty is an extremely favorable term -- but we can do better than aligning ourselves with what is arguably the most despised company in the pharmaceutical sector. I mean, really.
Also, I can't help but wonder where we might be on the Mono therapy indication in 8 months (up to 6 months for FDA approval, with actual product distribution happening some ~2 months afterward).
I know that Dr. NP mentioned Mono as a possible label expansion. Does anyone have a sense of when Mono approval might possibly happen?
Quote:I fully agree with you.
If the federal lawsuit kills Vyera to the point they can't make milestone payments all the better. We'll then take back the HIV indication.
In fact, nothing would make me happier than for Vyera to be in breach of the commercialization agreement due to lack of funds. I know that the negotiated 50% royalty is an extremely favorable term -- but we can do better than aligning ourselves with what is arguably the most despised company in the pharmaceutical sector. I mean, really.
Also, I can't help but wonder where we might be on the Mono therapy indication in 8 months (up to 6 months for FDA approval, with actual product distribution happening some ~2 months afterward).
I know that Dr. NP mentioned Mono as a possible label expansion. Does anyone have a sense of when Mono approval might possibly happen?
(1)
(0)
